Regulation of the heparan sulfate proteoglycan, perlecan, by injury and interleukin-1α

Journal of Neurochemistry

Volumn 73, Issue 2, 1999, Pages 812-820

  García de Yébenes, Esther ^a   Ho, Angela ^a   Damani, Tanuja ^a   Fillit, Howard ^a   Blum, Mariann ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Basic fibroblast growth factor; Inflammation; Injury; Interleukin 1; Perlecan

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; INTERLEUKIN 1ALPHA; PERLECAN; PROTEOHEPARAN SULFATE;

ARTICLE; GLIA CELL; HEPARINIZATION; HIPPOCAMPUS; IMMUNOCYTOCHEMISTRY; MALE; MOLECULAR CLONING; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEOGLYCAN SYNTHESIS; QUANTITATIVE DIAGNOSIS;

ALZHEIMER DISEASE; ANIMALS; BRAIN INJURIES; CELLS, CULTURED; CORPUS STRIATUM; ENCEPHALITIS; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; HEPARAN SULFATE PROTEOGLYCANS; HEPARITIN SULFATE; HIPPOCAMPUS; IN SITU HYBRIDIZATION; INJECTIONS, INTRAVENTRICULAR; INTERLEUKIN-1; MALE; MICE; MICE, INBRED C57BL; NEUROGLIA; PROTEOGLYCANS; RNA, MESSENGER; WOUNDS, STAB;

EID: 0032770311     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0730812.x     Document Type: Article

References (59)

1. Ailles L., Kisilevsky R., and Young I. D. (1993) Induction of perlecan gene expression precedes amyloid formation during experimental murine AA amyloidogenesis. Lab. Invest. 69, 443-448.
2. Aviezer D., Levy E., Safran M., Svahn C., Eckhart B., Schmidt A., David G., Vlodavsky I., and Yayon A. (1994) Differential structural requirements of heparin and heparin sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor. J. Biol. Chem. 269, 114-121.
3. Balasingam V., Tejada-Berges T., Wright E., Bouckova R., and Yong V. W. (1994) Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines. J. Neurosci. 14, 846-856.
4. Blum M. (1989) Regulation of neuroendocrine peptide gene expression, in Methods in Enzymology, Vol. 168 (Conn P. M., ed), pp. 618-633. Academic Press, San Diego.
5. Brodkey J. A., Laywell E. D., O'Brien T. F., Faissner A., Stefansson K., Dorries H. U., Schachner M., and Steindler D. A. (1995) Focal brain injury and upregulation of a developmentally regulated extracellular matrix protein. J. Neurosurg. 82, 106-112.
6. Buée L., Ding W., Anderson J. P., Narindrasorasak S., Kisilevsky R., Boyle N. J., Robakis N. K., Delacourte A., Greenberg B., and Fillit H. M. (1993a) Binding of vascular heparan sulfate proteoglycan to Alzheimer's disease amyloid precursor protein is mediated in part by the N-terminal region of A4 peptide. Brain Res. 627, 199-204.
7. Buée L., Ding W., Delacourte A., and Fillit H. (1993b) Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptide. Brain Res. 601, 154-163.
8. Castillo G. M., Ngo C., Cummings J., Wight T. N., and Snow A. D. (1997) Perlecan binds to the β-amyloid proteins (Aβ) of Alzheimer's disease, accelerates Aβ fibril formation, and maintains Aβ fibril stability. J. Neurochem. 69, 2452-2465.
9. Cotman C. W., Tenner A. J., and Cummings B. J. (1996) Beta-amyloid converts an acute phase injury response to chronic injury responses. Neurobiol. Aging 17, 723-731.
10. Couchman J. R. and Ljubimov A. V. (1989) Mammalian tissue distribution of a large heparan sulfate proteoglycan detected by monoclonal antibodies. Matrix 9, 311-321.
11. Cribbs D. H., Velazquez P., Soreghan B., Gable C. G., and Tenner A. J. (1997) Complement activation by cross-linked truncated and chimeric full-length β-amyloid. Neuroreport 8, 3457-3462.
12. Fillit H. M. and Leveugle B. (1995) Disorders of the extracellular matrix and the pathogenesis of senile dementia of the Alzheimer's type. Lab. Invest. 72, 249-253.
13. Gearing M., Wilson R. W., Unger E. R., Shelton E. R., Chan H. W., Masters C. L., Beyreuther K., and Mirra S. S. (1993) Amyloid precursor protein (APP) in the striatum in Alzheimer's disease: an immunohistochemical study. J. Neuropathol. Exp. Neurol. 52, 22-30.
14. Giulian D. and Lachman L. B. (1985) Interleukin 1 stimulation of astroglial proliferation after brain injury. Science 228, 497-499.
15. Giulian D., Young D. G., and Lachman L. B. (1986) Interleukin 1 of the central nervous system. Production by amoeboid microglia. J. Exp. Med. 164, 594-604.
16. Giulian D., Haverkamp L. J., Yu J. H., Karshin W., Tom D., Li J., Kirkpatrick J., Kuo Y. M., and Rohe A. E. (1996) Specific domains of β-amyloid from Alzheimer plaque elicit neuron killing in human microglia. J. Neurosci. 16, 6021-6037.
17. Gómez-Pinilla F., Cummings B. J., and Cotman C. W. (1990) Induction of basic fibroblast growth factor in Alzheimer's disease pathology. Neuroreport 1, 211-214.
18. Griffin W. S. T., Stanley L. C., Ling C., White L., McLeod V., Perrot L. J., White C. L., and Araoz C. (1989) Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. USA 86, 7611-7615.
19. Ho A, and Blum M. (1997) Regulation of astroglial-derived dopaminergic neurotrophic factors by interleukin-1β in the striatum of young and middle-aged mice. Exp. Neurol. 148, 348-359.
20. Klagsbrug M. and Baird A. (1991) A dual receptor system is required for basic fibroblast growth factor activity. Cell 67, 229-231.
21. Laywell E. D., Dorries U., Bartsch U., Faissner A., Schachner M., and Steindler D. A. (1992) Enhanced expression of the developmentally regulated extracellular matrix molecule tenascin following adult brain injury. Proc. Natl. Acad. Sci. USA 89, 2634-2638.
22. Le Roux D. P. and Reh A. T. (1994) Regional differences in glial-derived factors that promote dendritic outgrowth from mouse cortical neurons in vitro. J. Neurosci. 14, 4639-4655.
23. Leveugle B., Ding W., Durkin J. T., Mistretta S., Eisle J., Matic M., Siman R., Greenberg B. D., and Fillit H. M. (1997) Heparin promotes β-secretase cleavage of the Alzheimer's amyloid precursor protein. Neurochem. Int. 30, 543-548.
24. Leveugle B., Ding W., Laurence F., Dehouck M. P., Scanameo A., Cecchelli R., and Fillit H. (1998) Heparin oligosaccharides that pass the blood-brain barrier inhibit β-amyloid precursor protein secretion and heparin binding to β-amyloid peptide. J. Neurochem. 70, 736-744.
25. Logan A., Frautschy S.A., Gonzalez A. M. and Baird A. (1992) A time course for the focal elevation of synthesis of basic fibroblast growth factor and one of its high-affinity receptors (flg) following a localized cortical brain injury. J. Neurosci. 12, 3828-3837.
26. Mahley R. W., Weisgraber K. H., and Innerarity T. L. (1979) Interaction of plasma lipoproteins containing apolipoproteins B and E with heparin and cell surface receptors. Biochim. Biophys. Acta 575, 81-89.
27. McGeer P. L. and McGeer E. G. (1995) The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Brain Res. Rev. 21, 195-218.
28. Meda L., Cassatella M. A., Szendrei G. I., Otvos L. Jr., Baron P., Villalba M., Ferrari D., and Rossi F. (1995) Activation of microglial cells by β-amyloid protein and interferon. Nature 374, 647-650.
29. Merrill J. E. and Benveniste E. N. (1996) Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci. 19, 331-338.
30. Miller J. D., Cummings J., Maresh G. A., Walker D. G., Castillo G. M., Ngo C., Kimata K., Kinsella M. G., Wight T. N., and Snow A. D. (1997) Localization of perlecan (or a perlecan-related macromolecule) to isolated microglia in vitro and to microglia/macrophages following infusion of beta-amyloid protein into rodent hippocampus. Glia 21, 228-243.
31. Mortimer J. A., van Duijn C. M., Chandra V., Fratiglioni L., Graves A. B., Heyman A., Jorm A. F., Kokmen E., Kondo K., and Rocca W. A. (1991) Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int. J. Epidemiol. 20 (Suppl.), S28-S35.
32. Mrak R. E., Sheng J. G., and Giffin W. S. T. (1995) Glial cytokines in Alzheimer's disease: review and pathogenic implications. Hum. Pathol. 26, 816-823.
33. Murdoch A. D., Liu B., Schwarting R., Tuan R. S., and Iozzo R. V. (1994) Widespread expression of perlecan proteoglycan in basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against domain III and by in situ hybridization. J. Histochem. Cytochem. 42, 239-249.
34. Narindrasorasak S., Lowery D., Whitt P. G., Poorman R. A., Greenberg B., and Kisilevsky R. (1991) High affinity interactions between the Alzheimer's β-amyloid precursor proteins and the basement membrane form of heparan sulfate proteoglycan. J. Biol. Chem. 266, 12878-12883.
35. Nieto-Sampedro M. and Berman M. A. (1987) Interleukin-1 like activity in rat brain: sources, targets, and effect of injury. J. Neurosci. 17, 214-219.
36. Noonan D. M., Fulle A., Valente P., Cai S., Horigan E., Sasaki M., Yamada Y., and Hassell J. R. (1991) The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule. J. Biol. Chem. 266, 22939-22947.
37. Ornitz D., Yayon A., Flanagan J. G., Svahn C. M., Levi E., and Leder P. (1992) Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol. Cell. Biol. 12, 240-247.
38. Otero G. C. and Merrill J. E. (1994) Cytokine receptors on glial cells. Glia 11, 117-128.
39. Otsuka N., Tomonaga M., and Ikeda K. (1991) Rapid appearance of β-amyloid precursor protein immunoreactivity in damaged axons and reactive glial cells in rat brain following needle stab injury. Brain Res. 568, 335-338.
40. Perlmutter L. S., Chui H. C., Saperia D., and Athanikar J. (1990) Microangiopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer's disease. Brain Res. 508, 13-19.
41. Reier P. J. and Houle J. (1988) The glial scar: its bearing on axonal elongation and transplantation approaches to CNS repair, in Advances in Neurology, Vol. 47: Functional Recovery in Neurological Disease (Waxman S. G, ed), pp. 87-138. Raven Press, New York.
42. Rivera S., Gold S. J., and Gall C. M. (1994) Interleukin 1β increases basic fibroblast growth factor mRNA expression in adult rat brain and organotypic hippocampal cultures. Mol. Brain Res. 27, 12-26.
43. Roberts G. W., Allsop D., and Brunton C. (1990) The occult aftermath of boxing. J. Neurol. Neurosurg. Psychiatry 53, 373-378.
44. Rogers J., Webster S., Lue L. F., Brachova L., Civin W. H., Emmerling M., Shivers B., Walker D., and McGeer P. (1996) Inflammation and Alzheimer's disease pathogenesis. Neurobiol. Aging 17, 681-686.
45. Rostworowski M., Balasingam V., Chabot S., Owens T., and Yong V. W. (1997) Astrogliosis in the neonatal and adult murine brain post-trauma: elevation of inflammatory cytokines and the lack of requirement for endogenous interferon-γ J. Neurosci. 17, 3664-3674.
46. Shaffer L. M., Dority M. D., Gupta-Bansal R., Frederickson R. C., Younkin S. G., and Brunden K. R. (1995) Amyloid beta protein (Abeta) removal by neuroglial cells in culture. Neurobiol. Aging 16, 737-745.
47. Shee W. L., Ong W. Y., and Lim T. M. (1998) Distribution of perlecan in mouse hippocampus following intracerebroventricular kainate injections. Brain Res. 799, 292-300.
48. Shibayama M., Kuchiwaki H., Inao S., Yoshida K., and Ito M. (1996) Intercellular adhesion molecule-1 expression on glia following brain injury: participation of interleukin-1β. J. Neurotrauma 13, 801-808.
49. Shimasaki S., Emoto N., Koba A., Mercado M., Shibata F., Cooksey K., Baird A., and Ling N. (1988) Complementary DNA cloning and sequencing of rat ovarian basic fibroblast growth factor and tissue distribution study of its mRNA. Biochem. Biophys. Res. Commun. 157, 256-263.
50. Snow A. D., Mar H., Nochlin D., Kimata K., Kato M., Suzuki S., Hassell J., and Wight T. N. (1988) The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy of Alzheimer's disease. Am. J. Pathol. 133, 456-463.
51. Snow A. D., Mar H., Nochlin D., Sekiguchi R. T., Kimata K., Koike Y., and Wight T. N. (1990a) Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein containing lesions of Alzheimer's disease and Down's syndrome. Am. J. Pathol. 137, 1253-1270.
52. Snow A. D., Wight T. N., Nochlin D., Koike Y., Kitama K., DeArmond S. J., and Prusiner S. B. (1990b) Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann-Straussler syndrome, Creutzfeldt-Jakob disease and scrapie. Lab. Invest. 63, 601-611.
53. Snow A. D., Sekiguchi R., Nochlin D., Fraser P., Kimata K., Mizutani A., Arai M., Schreier W. A., and Morgan D. G. (1994a) An important role of heparan sulfate proteoglycan (perlecan) in a model system for the deposition and persistence of fibrillar β-amyloid in rat brain. Neuron 12, 219-234.
54. Snow A. D., Sekiguchi R., Nochlin D., Kalaria R. N., and Kimata K. (1994b) Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not in cerebellum of Alzheimer's disease brain. Am. J. Pathol. 144, 337-347.
55. Stopa G. E., Gonzalez A. M., Chorsky R., Corona J. R., Alvarez J., Bird D. E., and Baird A. (1990) Basic fibroblast growth factor in Alzheimer's disease. Biochem. Biophys. Res. Commun. 171, 690-696.
56. Su J. H., Cummings B. J., and Cotman C. W. (1992) Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease. Neuroscience 51, 801-813.
57. Tocco G., Freire-Moar J., Schreiber S. S., Sakhi S. H., Aise P. S., and Pasinetti G. M. (1997) Maturational regulation and regional induction of cyclooxygenase-2 in rat brain: implications for Alzheimer's disease. Exp. Neurol. 144, 339-349.
58. Wisniewski H. M., Bancher C., Barcikowska M., Wen G. Y., and Currie J. (1989) Spectrum of morphological appearance of amyloid deposits in Alzheimer's disease. Acta Neuropathol. (Berl.) 78, 337-347.
59. Yayon A., Klagsbrun M., Esko J. D., Leder P., and Ornitz D. M. (1991) Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64, 841-848.